Title 40

PART 79 SUBPART F

Subpart F - Testing Requirements for Registration Source:59 FR 33093, June 27, 1994, unless otherwise noted.

• 42 U.S.C. 7414, 7524, 7545 and 7601.
• Source: 40 FR 52011, Nov. 7, 1975, unless otherwise noted.

40:18.0.1.1.8.6.1.1	SECTION 79.50	79.50 Definitions.
40:18.0.1.1.8.6.1.2	SECTION 79.51	79.51 General requirements and provisions.
40:18.0.1.1.8.6.1.3	SECTION 79.52	79.52 Tier 1.
40:18.0.1.1.8.6.1.4	SECTION 79.53	79.53 Tier 2.
40:18.0.1.1.8.6.1.5	SECTION 79.54	79.54 Tier 3.
40:18.0.1.1.8.6.1.6	SECTION 79.55	79.55 Base fuel specifications.
40:18.0.1.1.8.6.1.7	SECTION 79.56	79.56 Fuel and fuel additive grouping system.
40:18.0.1.1.8.6.1.8	SECTION 79.57	79.57 Emission generation.
40:18.0.1.1.8.6.1.9	SECTION 79.58	79.58 Special provisions.
40:18.0.1.1.8.6.1.10	SECTION 79.59	79.59 Reporting requirements.
40:18.0.1.1.8.6.1.11	SECTION 79.60	79.60 Good laboratory practices (GLP) standards for inhalation exposure health effects testing.
40:18.0.1.1.8.6.1.12	SECTION 79.61	79.61 Vehicle emissions inhalation exposure guideline.
40:18.0.1.1.8.6.1.13	SECTION 79.62	79.62 Subchronic toxicity study with specific health effect assessments.
40:18.0.1.1.8.6.1.14	SECTION 79.63	79.63 Fertility assessment/teratology.
40:18.0.1.1.8.6.1.15	SECTION 79.64	79.64 In vivo micronucleus assay.
40:18.0.1.1.8.6.1.16	SECTION 79.65	79.65 In vivo sister chromatid exchange assay.
40:18.0.1.1.8.6.1.17	SECTION 79.66	79.66 Neuropathology assessment.
40:18.0.1.1.8.6.1.18	SECTION 79.67	79.67 Glial fibrillary acidic protein assay.
40:18.0.1.1.8.6.1.19	SECTION 79.68	79.68 Salmonella typhimurium reverse mutation assay.

---